Table 4.
Comorbid Condition | Combined Therapy (n = 175) | Monotherapy (n = 145) | p Value | ||
---|---|---|---|---|---|
No of comorbidities Median (IQR) | 2 (1–3) | 2 (0-3) | 0.29 | ||
Age Median (IQR) | 62.72 (39.2–73.2) | 62.84 (38.5–76.3) | 0.80 | ||
Diabetes mellites | 77 | 44% | 54 | 37% | 0.22 |
Chronic renal failure | 36 | 21% | 22 | 15% | 0.21 |
Active malignancy | 7 | 4% | 7 | 5% | 0.72 |
Immuno-suppressed | 4 | 2% | 5 | 3% | 0.53 |
Chronic Cardiac Diseases | 100 | 57% | 78 | 54% | 0.55 |
Chronic Resp. Disease | 20 | 11% | 15 | 10% | 0.76 |